INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 189 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $457,376 | -40.3% | 6,678 | -39.7% | 0.02% | -43.3% |
| Q1 2024 | $766,321 | -2.3% | 11,074 | +1.2% | 0.03% | -11.8% |
| Q4 2023 | $784,024 | +24.1% | 10,947 | -9.8% | 0.03% | -2.9% |
| Q3 2023 | $631,956 | -9.2% | 12,132 | +10.3% | 0.04% | -5.4% |
| Q2 2023 | $696,330 | +14.1% | 10,997 | -2.4% | 0.04% | -2.6% |
| Q1 2023 | $610,162 | +40.6% | 11,268 | +37.4% | 0.04% | +35.7% |
| Q4 2022 | $434,103 | +20.9% | 8,203 | +6.4% | 0.03% | +7.7% |
| Q3 2022 | $359,000 | -18.6% | 7,711 | -0.2% | 0.03% | -7.1% |
| Q2 2022 | $441,000 | -4.3% | 7,724 | +2.5% | 0.03% | +47.4% |
| Q1 2022 | $461,000 | +25.3% | 7,534 | +7.0% | 0.02% | +58.3% |
| Q4 2021 | $368,000 | +46.0% | 7,040 | +4.2% | 0.01% | +50.0% |
| Q3 2021 | $252,000 | -15.4% | 6,757 | -7.7% | 0.01% | -20.0% |
| Q2 2021 | $298,000 | +31.3% | 7,321 | +9.6% | 0.01% | +11.1% |
| Q1 2021 | $227,000 | +64.5% | 6,679 | -44.7% | 0.01% | 0.0% |
| Q4 2018 | $138,000 | -57.3% | 12,084 | -18.8% | 0.01% | -25.0% |
| Q3 2018 | $323,000 | – | 14,879 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
| Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
| Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
| WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
| SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
| Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
| EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
| Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |